{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:22:39Z","timestamp":1779913359437,"version":"3.53.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Anesth\/J Can Anesth"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s12630-017-0920-2","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T15:11:04Z","timestamp":1501600264000},"page":"1059-1070","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A primer on nerve agents: what the emergency responder, anesthesiologist, and intensivist needs to know","Une mise \u00e0 jour sur les agents neurotoxiques: ce que le premier r\u00e9pondant, l\u2019anesth\u00e9siologiste et l\u2019intensiviste doivent savoir"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4794-7261","authenticated-orcid":false,"given":"Keith","family":"Candiotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,1]]},"reference":[{"key":"920_CR1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/0885066603258659","volume":"19","author":"SW Wiener","year":"2004","unstructured":"Wiener SW, Hoffman RS. Nerve agents: a comprehensive review. J Intensive Care Med 2004; 19: 22-37.","journal-title":"J Intensive Care Med"},{"key":"920_CR2","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0196-0644(05)81036-4","volume":"21","author":"FR Sidell","year":"1992","unstructured":"Sidell FR, Borak J. Chemical warfare agents: II. Nerve agents. Ann Emerg Med 1992; 21: 865-71.","journal-title":"Nerve agents. Ann Emerg Med"},{"key":"920_CR3","unstructured":"de Bretton-Gordon H. Remembering Halabja chemical attack. Chemical weapons are the ultimate psychological weapon for those who are willing to use them - March 2016. Available from URL: http:\/\/www.aljazeera.com\/indepth\/opinion\/2016\/03\/remembering-halabja-chemical-attack-160316061221074.html (accessed June 2017)."},{"key":"920_CR4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3390\/toxics2030391","volume":"2","author":"R Pita","year":"2014","unstructured":"Pita R, Domingo J. The use of chemical weapons in the Syrian conflict. Toxics 2014; 2: 391-402.","journal-title":"Toxics"},{"key":"920_CR5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.emc.2014.09.010","volume":"33","author":"AM King","year":"2015","unstructured":"King AM, Aaron CK. Organophosphate and carbamate poisoning. Emerg Med Clin North Am 2015; 33: 133-51.","journal-title":"Emerg Med Clin North Am"},{"key":"920_CR6","unstructured":"Barnard A, Bishara Y, Rossback A, Saad H, Specia M; The New York Times. Evidence from Victims Points to Nerve Gas in Syria Attack - April 2017. Available from URL: https:\/\/www.nytimes.com\/interactive\/2017\/04\/04\/world\/middleeast\/syria-gas-attack.html (accessed June 2017)."},{"key":"920_CR7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0140-6736(95)92170-2","volume":"346","author":"H Morita","year":"1995","unstructured":"Morita H, Yanagisawa N, Nakajima T, et al. Sarin poisoning in Matsumoto. Japan. Lancet 1995; 346: 290-3.","journal-title":"Japan. Lancet"},{"key":"920_CR8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1553-2712.1998.tb02471.x","volume":"5","author":"T Okumura","year":"1988","unstructured":"Okumura T, Suzuki K, Fukuda A, et al. The Tokyo subway sarin attack: disaster management, part 2: hospital response. Acad Emerg Med 1988; 5: 618-24.","journal-title":"Acad Emerg Med"},{"key":"920_CR9","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(05)62271-4","volume":"350","author":"J Woodall","year":"1997","unstructured":"Woodall J. Tokyo subway gas attack. Lancet 1997; 350: 296.","journal-title":"Lancet"},{"key":"920_CR10","unstructured":"Paddock RC, Sang-Hun C, Wade N; The New York Times. In Kim Jong-nam\u2019s Death, North Korea Lets Loose a Weapon of Mass Destruction - February 24, 2017. Available from URL: https:\/\/www.nytimes.com\/2017\/02\/24\/world\/asia\/north-korea-kim-jong-nam-vx-nerve-agent.html?_r=0 (accessed June 2017)."},{"key":"920_CR11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0735-6757(99)90258-9","volume":"17","author":"F Morimoto","year":"1999","unstructured":"Morimoto F, Shimazu T, Yoshioka T. Intoxication of VX in humans. Am J Emerg Med 1999; 17: 493-4.","journal-title":"Am J Emerg Med"},{"key":"920_CR12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2006.06.008","volume":"249","author":"K Cannard","year":"2006","unstructured":"Cannard K. The acute treatment of nerve agent exposure. J Neuro Sci 2006; 249: 86-94.","journal-title":"J Neuro Sci"},{"key":"920_CR13","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1097\/00003246-200210000-00026","volume":"30","author":"JB Leikin","year":"2002","unstructured":"Leikin JB, Thomas RG, Walter FG, Klein R, Meislin HW. A review of nerve agent exposure for the critical care physician. Crit Care Med 2002; 30: 2346-54.","journal-title":"Crit Care Med"},{"key":"920_CR14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1742-7843.2006.pto_267.x","volume":"98","author":"K Kuca","year":"2006","unstructured":"Kuca K, Jun D, Cabal J, Hrabinova M, Bartosova L, Opletalova V. Russian VX: inhibition and reactivation of acetylcholinesterase compared with VX agent. Basic Clin Pharmacol Toxicol 2006; 98: 389-94.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"920_CR15","unstructured":"Mirzayanov VS. State Secrets: an Insider\u2019s Chronicle of the Russian Chemical Weapons Program. Denver (CO): Outskirts Press, Inc; 2009: 142-5, 179-80."},{"key":"920_CR16","unstructured":"Organisation for the Prohibition of Chemical Weapons. Nerve Agents. Available from URL: https:\/\/www.opcw.org\/protection\/types-of-chemical-agent\/nerve-agents\/ (accessed June 2017)."},{"key":"920_CR17","unstructured":"Army Study Guide. A non-government, privately sponsored website. Nerve Agents. Available from URL: http:\/\/www.armystudyguide.com\/content\/powerpoint\/CBRN_Presentations\/nerve-agents-2.shtml (accessed June 2017)."},{"key":"920_CR18","doi-asserted-by":"crossref","unstructured":"Bird SB, Gaspari RJ, Dickson EW. Early death due to severe organophosphate poisoning is a centrally mediated process. Acad Emerg Med 2003; 10: 295-8.","DOI":"10.1111\/j.1553-2712.2003.tb01338.x"},{"key":"920_CR19","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/j.1553-2712.2003.tb00001.x","volume":"10","author":"EW Dickson","year":"2003","unstructured":"Dickson EW, Bird SB, Gaspari RJ, Boyer EW, Ferris CF. Diazepam inhibits organophosphate-induced central respiratory depression. Acad Emerg Med 2003; 10: 1303-6.","journal-title":"Acad Emerg Med"},{"key":"920_CR20","doi-asserted-by":"crossref","unstructured":"Dekundy A, Kaminski RM, Zielinska E, Turski WA. NMDA antagonists exert distinct effects in experimental organophosphate or carbamate poisoning in mice. Toxicol Appl Pharmacol 2007; 219: 114-21.","DOI":"10.1016\/j.taap.2006.10.030"},{"key":"920_CR21","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1152\/jn.00949.2009","volume":"103","author":"M Kozhemyakin","year":"2010","unstructured":"Kozhemyakin M, Rajasekaran K, Kapur J. Central cholinesterase inhibition enhances glutamatergic synaptic transmission. J Neurophysiol 2010; 103: 1748-57.","journal-title":"J Neurophysiol"},{"key":"920_CR22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/bjaceaccp\/mkl052","volume":"6","author":"J Geoghegan","year":"2006","unstructured":"Geoghegan J, Tong JL. Chemical warfare agents. Contin Educ Anaesth Crit Care Pain 2006; 6: 230-4.","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"920_CR23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/1523-1747.ep12496487","volume":"68","author":"FN Craig","year":"1977","unstructured":"Craig FN, Cummings EG, Sim VM. Environmetal temperature and the percutaneous absorption of a cholinesterase inhibitor. VX. J Invest Dermatol 1977; 68: 357-61.","journal-title":"VX. J Invest Dermatol"},{"key":"920_CR24","first-page":"1267","volume-title":"Ellenhorn\u2019s Medical Toxicology: Diagnosis and Treatment of Human Poisoning","author":"MJ Ellenhorn","year":"1997","unstructured":"Ellenhorn MJ. Chemical warfare. In: Ellenhorn MJ, Schonwald S, Ordog G, Wesserberger OA, editors. Ellenhorn\u2019s Medical Toxicology: Diagnosis and Treatment of Human Poisoning. 2nd ed. Baltimore, MD: Williams and Wilkins Publishers; 1997. p. 1267-304.","edition":"2"},{"key":"920_CR25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7205\/MILMED.171.1.7","volume":"171","author":"A Cosar","year":"2006","unstructured":"Cosar A, Kenar L. An anesthesiological approach to nerve agent victims. Mil Med 2006; 171: 7-11.","journal-title":"Mil Med"},{"key":"920_CR26","unstructured":"U.S. Army Medical Research Institute of Chemical Defense. Medical Management of Chemical Casualties Handbook - Fourth Edition. Aberdeen Proving Ground, MD. Chemical Casualty Care Division; 2007: 122-56."},{"key":"920_CR27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00007611-199706000-00002","volume":"90","author":"S Ohbu","year":"1997","unstructured":"Ohbu S, Yamashina A, Takasu N, et al. Sarin poisoning on Tokyo subway. South Med J 1997; 90: 587-93.","journal-title":"South Med J"},{"key":"920_CR28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1054\/jocn.2001.1020","volume":"9","author":"H Okudera","year":"2002","unstructured":"Okudera H. Clinical features on nerve gas terrorism in Matsumoto. J Clin Neurosci 2002; 9: 17-21.","journal-title":"J Clin Neurosci"},{"key":"920_CR29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00005053-196404000-00009","volume":"138","author":"MB Bowers Jr","year":"1964","unstructured":"Bowers MB Jr, Goodman E, Sim VM. Some behavioral changes in man following anticholinesterase administration. J Neurol Ment Dis 1964; 138: 383-9.","journal-title":"J Neurol Ment Dis"},{"key":"920_CR30","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0272-0590(91)90183-5","volume":"17","author":"JD Bredow von","year":"1991","unstructured":"von Bredow JD, Adams NL, Groff WA, Vick JA. Effectiveness of oral pyridostigmine and cholinolytic-oxime therapy against soman intoxication in nonhuman primates. Fundam Appl Toxicol 1991; 17: 761-70.","journal-title":"Fundam Appl Toxicol"},{"key":"920_CR31","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/00000542-200210000-00035","volume":"97","author":"RB Abraham","year":"2002","unstructured":"Abraham RB, Rudick V, Weinbroum AA. practical guidelines for acute care of victims of bioterrorism: conventional injuries and concomitant nerve agent intoxication. Anesthesiology 2002; 97: 989-1004.","journal-title":"Anesthesiology"},{"key":"920_CR32","doi-asserted-by":"crossref","unstructured":"Benzenoff HE, McGee J, Knight V. The hypertensive response to soman and its relation to brain acetylcholinesterase inhibition. Acta Pharmacol Toxicol (Copenh)1984; 55: 270-7.","DOI":"10.1111\/j.1600-0773.1984.tb01981.x"},{"key":"920_CR33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0735-6757(00)90064-0","volume":"18","author":"T Kato","year":"2000","unstructured":"Kato T, Yoshimoto N, Sawano M, Hamabe Y. Coronary vasospasm in a patient suffering from sarin poisoning. Am J Emerg Med 2000; 18: 113-4.","journal-title":"Am J Emerg Med"},{"key":"920_CR34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0378-4274(87)90192-5","volume":"36","author":"AW Singer","year":"1987","unstructured":"Singer AW, Jaax NK, Graham JS, McCleod CG Jr. Cardiomyopathy in soman and sarin intoxicated rats. Toxicol Lett 1987; 36: 243-9.","journal-title":"Toxicol Lett"},{"key":"920_CR35","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0140-6736(95)92306-3","volume":"346","author":"H Nozaki","year":"1995","unstructured":"Nozaki H, Aikawa N, Fujishima S, et al. A case of VX poisoning and the difference from sarin. Lancet 1995; 346: 698-9.","journal-title":"Lancet"},{"key":"920_CR36","volume-title":"Advanced Hazmat Life support Provider Manual","author":"FG Walter","year":"2003","unstructured":"Walter FG. Advanced Hazmat Life support Provider Manual. 3rd ed. Tuckson: Arizona Board of Regents for the University of AZ; 2003 .","edition":"3"},{"key":"920_CR37","unstructured":"U.S. Department of Health & Human Services. Chemical Hazards Emergency Medical Management. Available from URL: https:\/\/chemm.nlm.nih.gov\/countermeasure_RSDL.htm (accessed June 2017)."},{"key":"920_CR38","doi-asserted-by":"crossref","DOI":"10.21236\/ADA398241","volume-title":"Medical Aspects of Chemical and Biological Warfare","author":"FR Sidell","year":"1997","unstructured":"Sidell FR, Takafuji ET, Franz DR. Medical Aspects of Chemical and Biological Warfare. Washington, DC: Office of the Surgeon General United States Army at TMM Publications; 1997 ."},{"key":"920_CR39","doi-asserted-by":"crossref","unstructured":"Chyka PA, Seger D, Krenzelok EP, Vale JA; American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. Position paper: Single dose activated charcoal. Clin Toxicol (Phila) 2005; 43: 61-87.","DOI":"10.1081\/CLT-51867"},{"key":"920_CR40","unstructured":"Paul J. Commercial pesticide applicators may get mandatory blood tests. Agrichemical Age 1987; March."},{"key":"920_CR41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5055\/ajdm.2012.0104","volume":"7","author":"KA Candiotti","year":"2012","unstructured":"Candiotti KA, Rodriguez Y, Shekhter I, et al. A comparison of different types of hazardous material respirators available to anesthesiologists. Am J Disaster Med 2012; 7: 313-9.","journal-title":"Am J Disaster Med"},{"key":"920_CR42","unstructured":"Occupational Safety and Health Administration. OSHA Best Practices for Hospital-Based First Receivers of Victims from Mass Casualty Incidents Involving the Release of Hazardous Substances. Available from URL: https:\/\/www.osha.gov\/dts\/osta\/bestpractices\/html\/hospital_firstreceivers.html (accessed June 2017)."},{"key":"920_CR43","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1553-2712.2003.tb02008.x","volume":"10","author":"J Perrone","year":"2003","unstructured":"Perrone J, Henretig F, Sims M, Beers M, Grippi MA. A role for ipratropium in chemical terrorism preparedness. Acad Emerg Med 2003; 10: 290.","journal-title":"Acad Emerg Med"},{"key":"920_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15563657408987971","volume":"7","author":"FR Sidell","year":"1974","unstructured":"Sidell FR. Soman and sarin: clinical manifestations and treatment of accidental poisoning by organophosphates. Clin Toxicol 1974; 7: 1-17.","journal-title":"Clin Toxicol"},{"key":"920_CR45","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/jps.2600780905","volume":"78","author":"KE Friedl","year":"1989","unstructured":"Friedl KE, Hannan CJ Jr, Schadler PW, Jacob WH. Atropine absorption after intramuscular administration with 2-pralidoxime choloride by two automatic injector devices. J Pharm Sci 1989; 78: 728-31.","journal-title":"J Pharm Sci"},{"key":"920_CR46","unstructured":"Dr. Richard S. Weisman (personal correspondence, March 17, 2017)."},{"key":"920_CR47","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.1989.03430050065028","volume":"262","author":"MA Dunn","year":"1989","unstructured":"Dunn MA, Sidell FR. Progress in medical defense against nerve agents. JAMA 1989; 262: 649-52.","journal-title":"JAMA"},{"key":"920_CR48","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/15376516.2016.1197992","volume":"26","author":"C Acon-Chen","year":"2016","unstructured":"Acon-Chen C, Koenig JA, Smith GR, Truitt AR, Thomas TP, Shih TM. Evaluation of acetylcholine, seizure activity and neuropathology following high-dose nerve agent exposure and delayed neuroprotective treatment drugs in freely moving rats. Toxicol Mech Methods 2016; 26: 378-88.","journal-title":"Toxicol Mech Methods"},{"key":"920_CR49","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF03012025","volume":"45","author":"PT Choi","year":"1998","unstructured":"Choi PT, Quinonez LG, Cook DJ, Baxter F, Whitehead L. The use of glycopyrrolate in a case of intermediate syndrome following acute organophosphate poisoning. Can J Anaesth 1998; 45: 337-40.","journal-title":"Can J Anaesth"},{"key":"920_CR50","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/0960327109350666","volume":"28","author":"R Arendse","year":"2009","unstructured":"Arendse R, Irusen E. An atropine and glycopyrrolate combination reduces mortality in organophosphate poisoning. Hum Exp Toxicol 2009; 28: 715-20.","journal-title":"Hum Exp Toxicol"},{"key":"920_CR51","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/074823378500100210","volume":"1","author":"WF Diller","year":"1985","unstructured":"Diller WF. Therapeutic strategy in phosgene poisoning. Toxicol Ind Health 1985; 1: 93-9.","journal-title":"Toxicol Ind Health"},{"key":"920_CR52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00063110-200309000-00003","volume":"10","author":"RB Abraham","year":"2003","unstructured":"Abraham RB, Weinbroum AA. Resuscitative challenges in nerve agent poisoning. Euro J Emerg Med 2003; 10: 169-75.","journal-title":"Euro J Emerg Med"},{"key":"920_CR53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ajem.2007.07.004","volume":"26","author":"KL Koenig","year":"2008","unstructured":"Koenig KL, Boatright CJ, Hancock JA, et al. Health care facility-based decontamination of victims exposed to chemical, biological, and radiological materials. Am J Emerg Med 2008; 26: 71-80.","journal-title":"Am J Emerg Med"},{"key":"920_CR54","doi-asserted-by":"crossref","unstructured":"Thiermann H, Aurbek N, Worek F. Treatment of nerve agent poisoning. In: Worek F, Jenner J, Thiermann H (Eds). Chemical Warfare Toxicology: Volume 2: Management of Poisoning. The Royal Society of Chemistry; 2016: 1-42.","DOI":"10.1039\/9781782628071-00001"},{"key":"920_CR55","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tox.2011.04.006","volume":"285","author":"PM Lundy","year":"2011","unstructured":"Lundy PM, Hamilton MG, Sawyer TW, Mikler J. Comparative protective effects of HI-6 and MMB-4 against organophosphorus nerve agent poisoning. Toxicology 2011; 285: 90-6.","journal-title":"Toxicology"},{"key":"920_CR56","unstructured":"Milan Patel (Regulatory Affairs Project Manager, Director Health Services Operations, Canadian Forces Health Services Group); Clinical Pharmacokinetics, Safety and Tolerance of HI-6 DMS and Comparative Bioequivalence of HI-6 2CI and HI-6 DMS, presented as an abstract at the Medical Chemical Defence Conference 2011; Munich, Germany 13-14 April 2011."},{"key":"920_CR57","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/096032719101000204","volume":"10","author":"R Kusic","year":"1991","unstructured":"Kusic R, Jovanovic D, Randjelovic S, et al. HI-6 in man: efficacy of the oxime in poisoning by organophosphorus insecticides. Hum Exp Toxicol 1991; 10: 113-8.","journal-title":"Hum Exp Toxicol"},{"key":"920_CR58","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/bja\/aef168","volume":"89","author":"SM White","year":"2002","unstructured":"White SM. Chemical and biological weapons. Implications for anaesthesia and intensive care. Br J Anaesth 2002; 89: 306-24.","journal-title":"Br J Anaesth"},{"key":"920_CR59","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0041-008X(70)90178-X","volume":"16","author":"EF Murtha","year":"1970","unstructured":"Murtha EF, Fleisher JH, Torre MA, Innerebner TA. Reactvatability of soman-inhibited end plate cholinesterase and neuromuscular transmission. Toxicol Appl Pharmacol 1970; 16: 214-26.","journal-title":"Toxicol Appl Pharmacol"},{"key":"920_CR60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0300-483X(92)90089-W","volume":"72","author":"PM Lundy","year":"1992","unstructured":"Lundy PM, Hansen AS, Hand BT, Boulet CA. Comparison of several oximes against poisoning by soman, tabun and GF. Toxicology 1992; 72: 99-105.","journal-title":"Toxicology"},{"key":"920_CR61","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/01.nrl.0000252923.04894.53","volume":"13","author":"J Newmark","year":"2007","unstructured":"Newmark J. Nerve agents. Neurologist 2007; 13: 20-32.","journal-title":"Neurologist"},{"key":"920_CR62","doi-asserted-by":"crossref","unstructured":"Shih T, McDonough JH Jr, Koplovitz I. Anticonvulsants for soman-induced seizure activity. J Biomed Sci 1999; 6: 86-96.","DOI":"10.1007\/BF02256439"},{"key":"920_CR63","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/milmed\/155.11.527","volume":"155","author":"JR Keeler","year":"1990","unstructured":"Keeler JR. Interactions between nerve agent pretreatment and drugs commonly used in combat anesthesia. Mil Med 1990; 155: 527-33.","journal-title":"Mil Med"},{"key":"920_CR64","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/milmed\/166.8.708","volume":"166","author":"D Risk","year":"2001","unstructured":"Risk D, Verpy D, Conley JD, Jacobson T, Sawyer TW. Volatile anesthestics give a false-positive reading in chemical agent monitors in the \u201cH\u201d mode. Mil Med 2001; 166: 708-10.","journal-title":"Mil Med"},{"key":"920_CR65","unstructured":"Baker DJ, Rustick JM. Anaesthesia for casualties of chemical warfare agents, anesthesia and perioperative care of the combat casualty. Office of the Surgeon General. United States Army Medical Department Center 1995; Part IV: 850."},{"key":"920_CR66","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/ALN.0b013e31819dabb0","volume":"110","author":"C Lee","year":"2009","unstructured":"Lee C, Jahr JS, Candiotti KA, Warriner B, Zornow MH, Naguib M. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium.: a comparison with spontaneous recovery from succinylcholine. Anesthesiology 2009; 110: 1020-5.","journal-title":"Anesthesiology"},{"key":"920_CR67","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1213\/01.ane.0000244594.63318.fc","volume":"104","author":"M Naguib","year":"2007","unstructured":"Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg 2007; 104: 575-81.","journal-title":"Anesth Analg"},{"key":"920_CR68","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1460-9592.2011.03692.x","volume":"22","author":"JX Mazoit","year":"2012","unstructured":"Mazoit JX. Local anesthetics and their adjuncts. Paediatr Anaesth 2012; 22: 31-8.","journal-title":"Paediatr Anaesth"},{"key":"920_CR69","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/archinte.1956.00250260095010","volume":"98","author":"D Grob","year":"1956","unstructured":"Grob D. The manifestations and treatment of poisoning due to nerve gas and other organic phosphate anticholinesterase compounds. Arch Intern Med 1956; 98: 221-6.","journal-title":"Arch Intern Med"},{"key":"920_CR70","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/096032719401300306","volume":"13","author":"HJ Silva de","year":"1994","unstructured":"de Silva HJ, Sanmuganathan PS, Senanayake N. Isolated bilateral recurrent laryngeal nerve paralysis: a delayed complication of organosphosphorous poisoning. Hum Exp Toxicol 1994; 13: 171-3.","journal-title":"Hum Exp Toxicol"},{"key":"920_CR71","first-page":"64","volume":"3","author":"S Laudari","year":"2014","unstructured":"Laudari S, Patowary BS, Sharma SK, et al. Cardiovascular effects of acute organophosphate poisoning. Asia Pac J Med Toxicol 2014; 3: 64-7.","journal-title":"Asia Pac J Med Toxicol"},{"key":"920_CR72","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.neuro.2016.12.004","volume":"58","author":"JL Winkler","year":"2017","unstructured":"Winkler JL, Skovira JW, Kan RK. Anticonvulsant efficacy of antihistamine cyproheptadine in rats exposed to the chemical warfare nerve agent soman. Neurotoxicity 2017; 58: 153-60.","journal-title":"Neurotoxicity"},{"key":"920_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.21886","author":"BA Reed","year":"2017","unstructured":"Reed BA, Sabourin CL, Lenz DE. Human butyrylcholinesterase efficacy against nerve agent exposure. J Biochem Mol Toxicol 2017; DOI: 10.1002\/jbt.21886 .","journal-title":"J Biochem Mol Toxicol"}],"updated-by":[{"DOI":"10.1007\/s12630-017-1005-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T00:00:00Z","timestamp":1511222400000}}],"container-title":["Canadian Journal of Anesthesia\/Journal canadien d'anesth\u00e9sie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12630-017-0920-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-017-0920-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-017-0920-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T18:50:29Z","timestamp":1569955829000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12630-017-0920-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,1]]},"references-count":73,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["920"],"URL":"https:\/\/doi.org\/10.1007\/s12630-017-0920-2","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12630-017-1005-y","asserted-by":"object"}]},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,1]]}}}